Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

October 25, 2018

Study Completion Date

October 25, 2018

Conditions
Primary Open Angle Glaucoma or Ocular Hypertension
Interventions
DRUG

AR-13324 Ophthalmic Solution 0.02%

Administered to each eye, once daily (QD) in the evening (PM) for 28 days

DRUG

AR-13324 Ophthalmic Solution 0.04%

Administered to each eye, once daily (QD) in the evening (PM) for 28 days

DRUG

AR-13324 Ophthalmic Solution Placebo

Administered to each eye, once daily (QD) in the evening (PM) for 28 days

Trial Locations (40)

10003

New York Eye Infirmary of Mount Sinai, New York

10016

The Shimmyo Group, New York

10065

Manhattan Eye Ear and Throat Hospital, New York

22046

Emerson Clinical Research Institute, Falls Church

29464

Glaucoma Consultants and Center for Eye Research, PA, Mt. Pleasant

30260

Clayton Eye Clinical Research, LLC, Morrow

37803

University Eye Specialists, Maryville

38120

VRF Eye Speciality Group, Memphis

40206

They Eye Care Institute, Louisville

43040

Optimed Research, Marysville

48105

University of Michigan, Ann Arbor

68198

University of Nebraska Medical Center, Omaha

78215

San Antonio Eye Center, San Antonio

78229

R and R Eye Research LLC, San Antonio

78572

DCT - Shah Research LLC dba Discovery Clinical Trials, Mission

78681

Round Rock Eye Consultants, Round Rock

78734

Lake Travis Eye and Laser Center, Lakeway

80910

MCB Clinical Research Centers LLC, Colorado Springs

85050

Arizona Glaucoma Specialists, Phoenix

85224

Arizona Eye Center, Chandler

89119

Emil A. Stein MD Ltd, Las Vegas

89123

AdvanceMed Clinical Research, Las Vegas

90013

East West Eye Institute, Los Angeles

90033

USC Roski Eye Institute University of Souther California, Los Angeles

90041

Global Research Foundation, Los Angeles

90270

Southern California Eye Physicians & Surgeons, Los Alamitos

91105

Southern California Eye Physicians Surgeons, Pasadena

91204

Global Research Management, Glendale

91506

Havana Research Institute, Burbank

91702

Milton M. Hom, OD FAAO FACAAISc, Azusa

92093

University of California, San Diego

92122

AdvanceMed Clinical Research, San Diego

92663

The Eye Research Foundation, Newport Beach

93110

Samsum Clinic, Santa Barbara

94105

Glaucoma Center of San Francisco, San Francisco

94954

North Bay Eye Associates Inc., Petaluma

95670

Martel Eye, Rancho Cordova

96704

Winward Eye Physicians and Eye Surgeons, Kailua

96740

Island Eye Care, Inc., Kailua

96814

Jenkins Eye Care, Honolulu

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT03310580 - Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter